NanoSphere Health Sciences, Inc. (NSHS.CX)
0.03
0.00 (0.00%)
CAD |
CNSX |
Jan 16, 16:00
NanoSphere Health Sciences Research and Development Expense (Quarterly): 0.00 for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biocure Technology, Inc. | -- |
| Core One Labs, Inc. | -- |
| Restart Life Sciences Corp. | 0.00 |
| Lobe Sciences Ltd. | 0.3392M |
| Algernon Health, Inc. | 0.0036M |